phenylalanine has been researched along with Daytime Sleepiness in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 19 (86.36) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Baladi, M; Bron, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ; Weaver, TE | 1 |
| Asin, J; Carter, LP; Chen, D; de Vries, N; Donjacour, CEHM; Janssen, H; Lammers, GJ; Overeem, S; Ramaekers, JG; Vermeeren, A; Vinckenbosch, F; Vonk, PE; Wang, G; Zhou, K | 1 |
| Baldys, B; Chen, A; Foley, C; Hyman, D; Ito, D; Parks, GS; Singh, H; Thorpy, MJ | 1 |
| Babson, K; Benca, RM; Bujanover, S; Krystal, AD; Lee, L; Malhotra, A; Rosenberg, R; Schweitzer, PK; Strohl, KP | 1 |
| Ahmed, M; Baladi, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ | 1 |
| Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, HA; Lammers, GJ; Lee, L; Mayer, G; Menno, D; Plazzi, G; Shapiro, CM; Thorpy, MJ; Villa, KF | 1 |
| Javaheri, S | 1 |
| Garland, S; Piszczatoski, C; Powell, J | 1 |
| Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, H; Lammers, GJ; Lee, L; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ | 1 |
| Earl, DC; Van Tyle, KM | 1 |
| Jha, D; K C, B; Ray, BK; Singh, R; Subedi, R; Thakur, RK | 1 |
| Baladi, M; Chandler, P; Lee, L; Malhotra, A; Mayer, G; Rosenberg, R; Schweitzer, PK; Strohl, KP | 1 |
| Baladi, M; Bron, M; Rosenberg, R | 1 |
| Chen, G; Gao, H; Li, X; Wang, J; Wang, T; Xu, X; Xu, Z; Yang, S | 1 |
| Baladi, M; Chandler, P; Gotfried, M; Malhotra, A; Mayer, G; Rosenberg, R; Schweitzer, PK; Strohl, KP; Zammit, GK | 1 |
| Amara, AW; Comella, C; Emsellem, H; Gottwald, MD; Hauser, RA; Jochelson, P; Liu, K; Schweitzer, PK; Steinerman, JR; Sterkel, AL; Videnovic, A; Zomorodi, K | 1 |
| Bujanover, S; Dauvilliers, Y; Gotfried, M; Malhotra, A; Rosenberg, R; Scheckner, B; Schweitzer, PK; Thorpy, MJ; Zammit, G | 1 |
| Bron, M; Bujanover, S; Kratochvil, D; Lucas, E; Menno, D; Patel, D; Ronnebaum, S; Stepnowsky, C | 1 |
| Belliard, S; Berrebi-Bertrand, I; Finance, O; Giret, M; Krief, S; Lecomte, JM; Ligneau, X; Nagmar, I; Perrin, D; Robert, P; Schwartz, JC; Uguen, M | 1 |
| Black, J; Carter, LP; Chen, D; Gotfried, M; Lu, Y; Malhotra, A; Rosenberg, R; Schweitzer, PK; Strohl, KP; Wang, H; Zammit, GK | 1 |
| Gao, J; Yang, J | 1 |
| Binns, PJ; Coderre, JA; Harling, OK; Hopewell, JW; Kiger, WS; Riley, KJ; Turcotte, JC | 1 |
7 review(s) available for phenylalanine and Daytime Sleepiness
| Article | Year |
|---|---|
Update on Persistent Excessive Daytime Sleepiness in OSA.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Modafinil; Phenylalanine; Piperidines; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents | 2020 |
Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
Topics: Carbamates; Clinical Trials as Topic; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents | 2020 |
New pharmacologic agents for insomnia and hypersomnia.
Topics: Azepines; Carbamates; Dementia; Disorders of Excessive Somnolence; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Phenylalanine; Piperidines; Pyridines; Pyrimidines; Sleep Aids, Pharmaceutical; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Trazodone; Triazoles; Zolpidem | 2020 |
Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive | 2020 |
Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Sleepiness | 2021 |
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
Topics: Benzhydryl Compounds; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Modafinil; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome | 2021 |
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy.
Topics: Adrenergic Uptake Inhibitors; Animals; Carbamates; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Humans; Narcolepsy; Phenylalanine; Treatment Outcome | 2019 |
11 trial(s) available for phenylalanine and Daytime Sleepiness
| Article | Year |
|---|---|
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Phenylalanine; Sleep Apnea, Obstructive | 2022 |
Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
Topics: Carbamates; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome | 2022 |
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
Topics: Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome | 2020 |
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Efficiency; Female; Humans; Male; Narcolepsy; Phenylalanine; Physical Functional Performance; Quality of Life; Surveys and Questionnaires; Wakefulness | 2020 |
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
Topics: Adult; Carbamates; Cataplexy; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine; Treatment Outcome; Wakefulness | 2020 |
Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy.
Topics: Carbamates; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Humans; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome | 2021 |
Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
Topics: Adolescent; Adult; Aged; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Patient Compliance; Phenylalanine; Sleep; Sleep Apnea, Obstructive; Wakefulness; Young Adult | 2021 |
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Parkinson Disease; Phenylalanine | 2021 |
Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Incidence; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Treatment Outcome | 2022 |
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
Topics: Adult; Aged; Carbamates; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Phenylalanine; Sleep Apnea, Obstructive | 2019 |
Tolerance of normal human brain to boron neutron capture therapy.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Disorders of Excessive Somnolence; Glioblastoma; Humans; Melanoma; Phenylalanine; Radiation Tolerance | 2004 |
4 other study(ies) available for phenylalanine and Daytime Sleepiness
| Article | Year |
|---|---|
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Quality of Life; Sleep Apnea, Obstructive | 2021 |
Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Female; Humans; Male; Middle Aged; Phenylalanine; Retrospective Studies; Sleep Apnea, Obstructive | 2022 |
Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive | 2021 |
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corpus Striatum; Disorders of Excessive Somnolence; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Drug Inverse Agonism; Feeding Behavior; Histamine Antagonists; Locomotion; Mice; Modafinil; Narcolepsy; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Phenylalanine; Piperidines; Receptors, Histamine H3; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents | 2021 |